AAAAAA

   
Results: 1-11 |
Results: 11
FIRST LINE CHEMOTHERAPY IN PATIENTS WITH BRAIN METASTASES FROM NONSMALL AND SMALL-CELL LUNG-CANCER
Authors: TUMMARELLO D LIPPE P BRACCI R MARI D MONTERUBBIANESI MC BATTELLI N
Citation: D. Tummarello et al., FIRST LINE CHEMOTHERAPY IN PATIENTS WITH BRAIN METASTASES FROM NONSMALL AND SMALL-CELL LUNG-CANCER, Oncology Reports, 5(4), 1998, pp. 897-900
POSITIVE IMMUNOSTAINING WITH MLUC1 OF BONE-MARROW ASPIRATE PREDICTS POOR OUTCOME IN PATIENTS WITH SMALL-CELL LUNG-CANCER
Authors: PASINI F PELOSI G VERLATO G GUIDI G PAVANEL F TUMMARELLO D MASOTTI A CETTO GL
Citation: F. Pasini et al., POSITIVE IMMUNOSTAINING WITH MLUC1 OF BONE-MARROW ASPIRATE PREDICTS POOR OUTCOME IN PATIENTS WITH SMALL-CELL LUNG-CANCER, Annals of oncology, 9(2), 1998, pp. 181-185
A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES
Authors: TUMMARELLO D MARI D GRAZIANO F ISIDORI P CETTO G PASINI F SANTO A CELLERINO R
Citation: D. Tummarello et al., A RANDOMIZED, CONTROLLED PHASE-III STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE WITH ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T), FOLLOWED BY RECOMBINANT INTERFERON-ALPHA MAINTENANCE THERAPY OR OBSERVATION, IN SMALL-CELL LUNG-CARCINOMA PATIENTS WITH COMPLETE RESPONSES, Cancer, 80(12), 1997, pp. 2222-2229
ASSESSING QUALITY-OF-LIFE IN PATIENTS WITH CANCER - A COMPARISON OF AVISUAL-ANALOG AND A CATEGORICAL MODEL
Authors: GIORGI F CELLERINO R GRAMAZIO A TUMMARELLO D MENICHETTI ET GIORDANI P ANTOGNOLI S CARLE F PIGA A
Citation: F. Giorgi et al., ASSESSING QUALITY-OF-LIFE IN PATIENTS WITH CANCER - A COMPARISON OF AVISUAL-ANALOG AND A CATEGORICAL MODEL, American journal of clinical oncology, 19(4), 1996, pp. 394-399
ADVANCED NONSMALL CELL LUNG-CANCER (ANSCLC) - NEW CHEMOTHERAPY PHASE-II STUDIES AND OLD FAULTS
Authors: TUMMARELLO D GRAZIANO F
Citation: D. Tummarello et F. Graziano, ADVANCED NONSMALL CELL LUNG-CANCER (ANSCLC) - NEW CHEMOTHERAPY PHASE-II STUDIES AND OLD FAULTS, Lung cancer, 15(3), 1996, pp. 375-376
CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY
Authors: TUMMARELLO D GRAZIANO F ISIDORI P SANTO A CETTO G FEDELI A ROSSI G CELLERINO R
Citation: D. Tummarello et al., CONSOLIDATION BIOCHEMOTHERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CARCINOMA RESPONDING TO INDUCTION PVM (CISPLATIN, VINBLASTINE, MITOMYCIN-C) REGIMEN - A PHASE-II STUDY, Cancer, 77(11), 1996, pp. 2251-2257
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
Authors: ALBERTI W ANDERSON G BARTOLUCCI A BELL D VILLALBA JB BRODIN O CARDIELLO C CARTEI F CARTEI G CELLERINO R CHASTANG C CORMIER Y COX JD CRINO L CROWLEY J DAUTZENBERG B DEPIERRE A DIETEMANN A DILLMAN RO DOI O FELD R FIGLIN R GANZ PA GREEN MR GREGOR A HELLE PA HERNDON JE HITOMI S HOST H IMAIZUMI M JETT JR JOHNSON D KAASA S KIMURA H KLASTERSKY J KONDO H KREISMAN H KRIS MG KUNISHIMA K KUWAHARA O LAD TE LAING AH MACBETH F MASAOKA A MATTSON K MINATEL E MIRA JG MORI T MOUNTAIN CF NIEDERLE N NIIRANEN A NOU E PAGE W PATER J PIANTADOSI S PISTERS KMW PYRHONEN S QUOIX E RAPP E ROWELL NP SAHMOUD T SAWAMURA K SCHALLIER DCC SCOTT C SIMPSON J STAGG M TERAMATSU T TROVO MG TSUCHIYA R TUMMARELLO D VANHOUTTE P VANZANDWIJK N VINCENT RG WADA H WHITE JE WILLIAMS CJ WOODS RL YAMAGUCHI Y ARRIAGADA R CARTMELLDAVIES J GIRLING DJ LECHEVALIER T MARSONI S PARMAR MKB PIGNON JP REKACEWICZ C SOUHAMI RL STEWART LA TARAYRE M TINAZZI A TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C
Authors: TUMMARELLO D GRAZIANO F ISIDORI P CELLERINO R
Citation: D. Tummarello et al., SYMPTOMATIC, STAGE-IV, NON-SMALL-CELL LUNG-CANCER (NSCLC) - RESPONSE,TOXICITY, PERFORMANCE STATUS CHANGE AND SYMPTOM RELIEF IN PATIENTS TREATED WITH CISPLATIN, VINBLASTINE AND MITOMYCIN-C, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 249-253
CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE
Authors: TUMMARELLO D ISIDORI P GRAZIANO F MARI D CELLERINO R
Citation: D. Tummarello et al., CHEMOTHERAPEUTIC TREATMENT IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - A FURTHER ATTEMPT TO MODULATE CISPLATIN, VINBLASTINE AND MITOMYCIN-C (PVM) SCHEDULE, Oncology Reports, 1(2), 1994, pp. 415-418
SMALL-CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE PLUS ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T) AS INDUCTION TREATMENT, FOLLOWED IN COMPLETE RESPONDERS BY ALPHA-INTERFERON OR NO TREATMENT, AS MAINTENANCE THERAPY
Authors: TUMMARELLO D GRAZIANO F MARI D CETTO G PASINI F ANTONIO S ISIDORI P GASPARINI S
Citation: D. Tummarello et al., SMALL-CELL LUNG-CANCER (SCLC) - A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, VINCRISTINE PLUS ETOPOSIDE (CAV-E) OR TENIPOSIDE (CAV-T) AS INDUCTION TREATMENT, FOLLOWED IN COMPLETE RESPONDERS BY ALPHA-INTERFERON OR NO TREATMENT, AS MAINTENANCE THERAPY, Anticancer research, 14(5B), 1994, pp. 2221-2227
FACTORS INFLUENCING RESPONSE TO 2ND-LINE TREATMENT WITH TENIPOSIDE (VM26) IN PATIENTS WITH PROGRESSIVE SMALL-CELL LUNG-CANCER (SCLC)
Authors: TUMMARELLO D GRAZIANO F GIORDANI P CELLERINO R
Citation: D. Tummarello et al., FACTORS INFLUENCING RESPONSE TO 2ND-LINE TREATMENT WITH TENIPOSIDE (VM26) IN PATIENTS WITH PROGRESSIVE SMALL-CELL LUNG-CANCER (SCLC), Anticancer research, 13(4), 1993, pp. 1055-1058
Risultati: 1-11 |